The Program Manager partners closely with subject matter experts across Toxicology, DMPK/ADME, Bioanalytical Sciences, Clinical Pharmacology, Clinical Pharmacology Bioanalytical, and Pharmacometrics, and interacts with stakeholders across Research, CMC, Clinical Development, Regulatory Affairs, Finance, and Program Management to facilitate alignment on program strategy, milestones, risks, timelines, resources, and critical-path activities. Partners with Cross-Functional Program Management, CMC Functional Program Management, Regulatory Affairs, and other stakeholders to ensure that asset-level strategic decisions are effectively translated into coordinated functional execution and that emerging Preclinical risks and dependencies are appropriately communicated into broader asset governance.